Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
71.55
+0.35 (0.49%)
Nov 25, 2025, 4:00 PM EST - Market closed
Avidity Biosciences Market Cap
Avidity Biosciences has a market cap or net worth of $10.78 billion as of November 25, 2025. Its market cap has increased by 93.41% in one year.
Market Cap
10.78B
Enterprise Value
8.95B
1-Year Change
93.41%
Ranking
Category
Stock Price
$71.55
Market Cap Chart
Since June 12, 2020, Avidity Biosciences's market cap has increased from $1.01B to $10.78B, an increase of 970.06%. That is a compound annual growth rate of 54.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 25, 2025 | 10.78B | 210.73% |
| Dec 31, 2024 | 3.47B | 417.36% |
| Dec 29, 2023 | 670.62M | -54.52% |
| Dec 30, 2022 | 1.47B | 32.27% |
| Dec 31, 2021 | 1.11B | 16.40% |
| Dec 31, 2020 | 957.68M | -4.94% |
| Jun 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 993.82B |
| Johnson & Johnson | 497.93B |
| AbbVie | 409.68B |
| UnitedHealth Group | 295.56B |
| AstraZeneca | 288.24B |
| Merck & Co. | 262.25B |
| Novartis AG | 248.38B |
| Thermo Fisher Scientific | 224.59B |